442 related articles for article (PubMed ID: 28578382)
1. Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation.
Dong Z; Zhao P; Xu M; Zhang C; Guo W; Chen H; Tian J; Wei H; Lu R; Cao T
Sci Rep; 2017 Jun; 7(1):2691. PubMed ID: 28578382
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPARα pathway.
Chen X; Wang Q; Shao M; Ma L; Guo D; Wu Y; Gao P; Wang X; Li W; Li C; Wang Y
Biomed Pharmacother; 2019 Dec; 120():109487. PubMed ID: 31577975
[TBL] [Abstract][Full Text] [Related]
3. Activating PPARα prevents post-ischemic contractile dysfunction in hypertrophied neonatal hearts.
Lam VH; Zhang L; Huqi A; Fukushima A; Tanner BA; Onay-Besikci A; Keung W; Kantor PF; Jaswal JS; Rebeyka IM; Lopaschuk GD
Circ Res; 2015 Jun; 117(1):41-51. PubMed ID: 25977309
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure.
Tang B; Zhang JG; Tan HY; Wei XQ
Biosci Rep; 2018 May; 38(3):. PubMed ID: 29301869
[TBL] [Abstract][Full Text] [Related]
5. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
Fukushima A; Milner K; Gupta A; Lopaschuk GD
Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
Huss JM; Torra IP; Staels B; Giguère V; Kelly DP
Mol Cell Biol; 2004 Oct; 24(20):9079-91. PubMed ID: 15456881
[TBL] [Abstract][Full Text] [Related]
7. Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism.
Sun D; Yang F
Biochem Biophys Res Commun; 2017 Apr; 486(2):329-335. PubMed ID: 28302481
[TBL] [Abstract][Full Text] [Related]
8. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.
Hafstad AD; Khalid AM; Hagve M; Lund T; Larsen TS; Severson DL; Clarke K; Berge RK; Aasum E
Cardiovasc Res; 2009 Aug; 83(3):519-26. PubMed ID: 19398469
[TBL] [Abstract][Full Text] [Related]
9. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
[TBL] [Abstract][Full Text] [Related]
10. Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.
Tsuda M; Fukushima A; Matsumoto J; Takada S; Kakutani N; Nambu H; Yamanashi K; Furihata T; Yokota T; Okita K; Kinugawa S; Anzai T
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):844-859. PubMed ID: 30168279
[TBL] [Abstract][Full Text] [Related]
11. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
12. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
[TBL] [Abstract][Full Text] [Related]
13. PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis.
Standage SW; Bennion BG; Knowles TO; Ledee DR; Portman MA; McGuire JK; Liles WC; Olson AK
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H239-H249. PubMed ID: 27881386
[TBL] [Abstract][Full Text] [Related]
14. Exploring the protective effects of PNS on acute myocardial ischaemia-induced heart failure by Transcriptome analysis.
Chen X; Ma L; Shao M; Wang Q; Jiang Q; Guo D; Zhang P; Yang R; Li C; Wang Y; Wang W
J Ethnopharmacol; 2021 May; 271():113823. PubMed ID: 33472092
[TBL] [Abstract][Full Text] [Related]
15. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure.
Osorio JC; Stanley WC; Linke A; Castellari M; Diep QN; Panchal AR; Hintze TH; Lopaschuk GD; Recchia FA
Circulation; 2002 Jul; 106(5):606-12. PubMed ID: 12147544
[TBL] [Abstract][Full Text] [Related]
16. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
Scolletta S; Biagioli B
Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
[TBL] [Abstract][Full Text] [Related]
17. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
[TBL] [Abstract][Full Text] [Related]
18. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cardiac fatty acids metabolism in transgenic mice overexpressing bovine GH.
Bogazzi F; Raggi F; Ultimieri F; Russo D; D'Alessio A; Manariti A; Brogioni S; Manetti L; Martino E
J Endocrinol; 2009 Jun; 201(3):419-27. PubMed ID: 19342398
[TBL] [Abstract][Full Text] [Related]
20. Branched chain amino acids exacerbate myocardial ischemia/reperfusion vulnerability via enhancing GCN2/ATF6/PPAR-α pathway-dependent fatty acid oxidation.
Li Y; Xiong Z; Yan W; Gao E; Cheng H; Wu G; Liu Y; Zhang L; Li C; Wang S; Fan M; Zhao H; Zhang F; Tao L
Theranostics; 2020; 10(12):5623-5640. PubMed ID: 32373236
[No Abstract] [Full Text] [Related]
[Next] [New Search]
